Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108558715A details high-yield route. Reduces cost and environmental impact for pharmaceutical intermediates manufacturing significantly.
Patent CN109456211A enables high-purity synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Deep dive into CN104072390B. Advanced impurity control for S-escitalopram. Reliable supply chain and cost-effective manufacturing solutions for global pharma.
Patent CN101787032A reveals a cost-effective clopidogrel synthesis using D-camphorsulfonic acid resolution, offering high purity and scalable manufacturing for global supply chains.
Patent CN115010686A details a novel resolution for 2-oxabicyclo-[3.3.0]oct-6-en-3-one, offering high purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN101910124A details a high-purity 3-aminopyrrolidine salt production via MPAA resolution, offering cost-effective aqueous processing for pharmaceutical intermediates.
Novel epoxidation-ring opening route for antiviral intermediates. Reduces cost and improves purity compared to lithium aluminum hydride methods. Reliable supplier.
Advanced preparation method for Non-neridone intermediates via CN116082334A. High-yield resolution and scalable cyanation for cardiovascular API manufacturing.
Patent CN109232184B details a chiral resolution method for L-isopulegol ensuring high optical purity and yield suitable for industrial menthol production.
Patent CN101343267A reveals novel inclusion resolution for Pantoprazole. Achieve high purity and stability with reduced manufacturing costs for supply chains.
Patent CN104151352B reveals a high-purity Sofosbuvir intermediate method. This report analyzes cost reduction and supply chain advantages for pharmaceutical manufacturing.
Patent CN1161689A enables high-purity levobupivacaine production with reduced resolving agent usage and improved supply chain reliability for pharmaceutical manufacturers globally.
Patent CN101570550A details a scalable, chromatography-free route for chiral ferrocene ligands, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel chiral resolving agent enables high-purity (R)-o-chloromandelic acid production. Mature industrial route ensures supply chain stability and cost efficiency for pharmaceutical intermediates.
Patent CN101007772B reveals a cost-effective Strecker synthesis for chiral norvaline, offering significant supply chain advantages for perindopril manufacturing.
Patent CN1642928A details novel routes for high-purity morpholine derivatives. Discover cost-effective enzymatic and chiral pool strategies for API manufacturing.
Patent CN105348172B details a green synthesis route for Apremilast intermediates. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN112939911A reveals a novel chiral resolution process for L-Corey lactone intermediates, offering high optical purity and scalable manufacturing for prostaglandin synthesis.
Patent CN119613414A reveals high-yield Fezolinetant route. Offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN1759097A details a safer process for PDF inhibitor intermediates using specific beta-lactams and selective debenzylation, offering significant cost reduction in pharmaceutical intermediate manufacturing.